Inventors:
Joseph Baggott - Mountain Brook AL, US
Sarah Morgan - Vestavia AL, US
International Classification:
A61K031/525, A61K009/48, A61K009/20, A61K031/519
US Classification:
514/251000, 424/451000, 424/464000, 514/258000
Abstract:
The deleterious symptoms of autoimmune disease in a patient suffering from symptoms of autoimmune disease can be relieved by by co-administration of a cell-mediated immune inhibiting effective amount of at least one inhibitor of dihydrofolate reductase and a folate wherein the folate is formulated for delayed release in a carrier.